Catalogo dei prodotti della ricerca

MARCHETTI, CLAUDIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.071
EU - Europa 1.864
AS - Asia 1.337
SA - Sud America 79
AF - Africa 62
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 9.418
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.986
SG - Singapore 716
IT - Italia 699
IN - India 290
SE - Svezia 269
CN - Cina 255
FI - Finlandia 183
DE - Germania 179
RU - Federazione Russa 137
UA - Ucraina 90
CA - Canada 73
BR - Brasile 55
IE - Irlanda 50
GB - Regno Unito 49
TG - Togo 46
BG - Bulgaria 45
FR - Francia 36
BE - Belgio 24
GR - Grecia 23
RO - Romania 21
NL - Olanda 19
AR - Argentina 17
TR - Turchia 14
ID - Indonesia 13
PK - Pakistan 11
MX - Messico 10
IR - Iran 9
AT - Austria 8
ES - Italia 8
LT - Lituania 6
CH - Svizzera 5
PL - Polonia 5
ZA - Sudafrica 5
AU - Australia 4
CO - Colombia 4
HK - Hong Kong 4
UZ - Uzbekistan 4
BD - Bangladesh 3
MA - Marocco 3
AE - Emirati Arabi Uniti 2
CZ - Repubblica Ceca 2
IQ - Iraq 2
KR - Corea 2
KZ - Kazakistan 2
MU - Mauritius 2
PA - Panama 2
SC - Seychelles 2
BA - Bosnia-Erzegovina 1
BJ - Benin 1
EC - Ecuador 1
EE - Estonia 1
EG - Egitto 1
EU - Europa 1
GE - Georgia 1
HU - Ungheria 1
IL - Israele 1
IM - Isola di Man 1
JO - Giordania 1
KE - Kenya 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MY - Malesia 1
NP - Nepal 1
PE - Perù 1
TJ - Tagikistan 1
TN - Tunisia 1
TW - Taiwan 1
UY - Uruguay 1
VN - Vietnam 1
Totale 9.418
Salva come PNG Salva come JPEG
Città #
Fairfield 1.172
Ashburn 498
Woodbridge 474
Seattle 410
Houston 390
Singapore 377
Cambridge 338
Wilmington 337
Chandler 328
Rome 280
Ann Arbor 180
Beijing 173
Princeton 166
Santa Clara 141
Plano 134
Dearborn 130
San Paolo di Civitate 105
Millbury 87
Lawrence 80
Cosenza 79
Helsinki 78
San Diego 66
Bremen 61
Boston 60
Dublin 48
Lomé 46
Sofia 45
Andover 43
Toronto 33
Norwalk 29
Brussels 23
Jacksonville 22
Moscow 22
North York 22
New York 20
Des Moines 19
Falkenstein 19
Fremont 18
Florence 16
Falls Church 15
Redwood City 15
Kunming 14
Federal 13
Jakarta 13
Los Angeles 13
Yubileyny 13
Milan 12
Boardman 11
Istanbul 11
Mannheim 11
Ottawa 11
Council Bluffs 9
Nanjing 9
Phoenix 9
London 8
Turin 8
Hefei 7
Mexico City 7
Jinan 6
Portsmouth 6
Fort Worth 5
Hyderabad 5
Lauterbourg 5
Monterotondo 5
Southend 5
São Paulo 5
Bühl 4
Changsha 4
Gurgaon 4
Hebei 4
Rio de Janeiro 4
San Mateo 4
Valencia 4
Vienna 4
Wuhan 4
Amsterdam 3
Antalya 3
Bern 3
Chicago 3
Deventer 3
Düsseldorf 3
Frankfurt am Main 3
Hong Kong 3
Lyon 3
Nanchang 3
Pomezia 3
Prossedi 3
Redmond 3
Tashkent 3
Torino 3
Velletri 3
Albany 2
Albuquerque 2
Athens 2
Athlone 2
Baotou 2
Belo Horizonte 2
Bogotá 2
Calenzano 2
Catanzaro 2
Totale 6.922
Salva come PNG Salva come JPEG
Nome #
MiR-200c sensitizes Olaparib-resistant ovarian cancer cells by targeting Neuropilin 1 133
Rucaparib. An emerging parp inhibitor for treatment of recurrent ovarian cancer 132
NEOADJUVANT CHEMOTHERAPY FOLLOWED BY RADICAL SURGERY IN PATIENTS AFFECTED BY VAGINAL CARCINOMA 121
Brain metastases from malignant Brenner tumor of the ovary. a case report and a literature review 115
Fertility preservation in gynaecologic cancers 113
Dose-dense weekly chemotherapy in advanced ovarian cancer: an updated meta-analysis of randomized controlled trials 111
Type B versus Type C Radical Hysterectomy After Neoadjuvant Chemotherapy in Locally Advanced Cervical Carcinoma: A Propensity-Matched Analysis 110
Risk-reducing salpingo-oophorectomy in BRCA1 and BRCA2 mutated patients: an evidence-based approach on what women should know 109
Restoring vaginal microbiota: biological control of bacterial vaginosis. A prospective case-control study using Lactobacillus rhamnosus BMX 54 as adjuvant treatment against bacterial vaginosis 108
Autologous In Vitro Cultured Vaginal Tissue for Women Subjected to the Abbe-McIndoe Vaginoplasty: A Case Series 107
Bevacizumab in ovarian cancer: state of the art and unanswered questions 106
Update on fertility-sparing treatment in primary and recurrent endometrial cancer 101
Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial. 100
Hormone replacement therapy after prophylactic risk-reducing salpingo-oophorectomy and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a meta-analysis 99
Comparison of anogenital distance and correlation with vulvo-vaginal atrophy: a pilot study on premenopausal and postmenopausal women 97
Immune check-point in cervical cancer 97
Advances in anti-angiogenic agents for ovarian cancer treatment: the role of trebananib (AMG 386) 96
Impact of hormone receptor status and Ki-67 expression on disease-free survival in patients affected by high-risk endometrial cancer 96
Perivascular epithelioid cell neoplasm (PEComa) of the uterus: a systematic review 96
Ixabepilone for the treatment of endometrial cancer 96
Tyrosine-kinases inhibitors in recurrent platinum-resistant ovarian cancer patients 95
Weekly versus three weeks chemotherapy for advanced ovarian cancer: a meta-analysis 94
PARP inhibition: a promising therapeutic target in ovarian cancer 94
A prospective phase II study of topotecan (Hycamtin®) and cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer. 90
Surgical treatment of an isolated omental cervical cancer recurrence: Report of a case and review of the literature 89
Solitary gastric recurrence from ovarian carcinoma: A case report and literature review 88
Valutazione del ruolo prognostico dei sottotipi istologici nei carcinomi papilliferi della tiroide con particolare riferimento della variante in sclerosi diffusa. 88
Chemotherapy in elderly patients with gynecological cancer 87
Ovarian cancer cytoreduction induces changes in T cell population subsets reducing immunosuppression 87
Cervical cancer: are there potential new targets? An update on preclinical and clinical results 87
Survival nomograms after curative neoadjuvant chemotherapy and radical surgery for stage IB2-IIIB cervical cancer 87
Vulvo-vaginal reconstruction after radical excision for treatment of vulvar cancer: evaluation of feasibility and morbidity of different surgical techniques 86
Cediranib in ovarian cancer. state of the art and future perspectives 85
null 85
Brain metastases in patients with EOC: clinico-pathological and prognostic factors. A multicentric retrospective analysis from the MITO group (MITO 19) 85
Role of intraperitoneal chemotherapy in ovarian cancer in the platinum-taxane-based era: a meta-analysis 85
Mid-trimester isolated short femur and perinatal outcomes: a systematic review and meta-analysis 82
CO2 laser therapy of the Bartholin's gland cyst: surgical data and functional short- and long-term results. 81
Efficacy and toxicity of bevacizumab in recurrent ovarian disease: an update meta-analysis on phase III trials 81
Sexual health and quality of life assessment among ovarian cancer patients during chemotherapy 80
Defective DNA repair mechanisms in prostate cancer: impact of olaparib 79
null 78
Management of endometriomas 78
Multiple Bulky Lymph Nodal Metastasis in Microinvasive Cervical Cancer: A Case Report and Literature Review. 78
Current knowledge and open issues regarding Bevacizumab in gynaecological neoplasms 78
Role of chemotherapy in the management of vulvar carcinoma 77
Screening program in ovarian cancer: a logical step in clinical management? A meta-analysis 76
Adjuvant chemotherapy does not improve disease-free survival in FIGO stage IC ovarian granulosa cell tumors: the MITO-9 study 76
An unexpected complete remission of advanced intestinal-type vulvar adenocarcinoma after neoadjuvant chemotherapy: a case report and a literature review. 74
null 72
Reactive lymphoid hyperplasia of liver mimicking late ovarian cancer recurrence: case report and literature review. 72
Beyond the beyond: first case of 9 cytoreductive surgeries in a long-surviving ovarian cancer patient: case report 72
Corrigendum to “Bartholin gland cancer” (Bartholin gland cancer (2017) 117 (1–11) 72
Dualistic classification of epithelial ovarian cancer: Surgical and survival outcomes in a large retrospective series 72
CO2 Laser Treatment for Bartholin Gland Abscess: Ultrasound Evaluation of Risk Recurrence 71
Metformin reduces maternal weight gain in obese pregnant women: a systematic review and meta‐analysis of two randomized controlled trials 71
Dose-Dense Neoadjuvant Chemotherapy plus Radical Surgery in Locally Advanced Cervical Cancer: A Phase II Study 70
Effects of neoadjuvant chemotherapy plus radical surgery as front line treatment strategy in patients affected by FIGO stage III cervical cancer 70
MODIFIED GLUTEAL FOLD ADVANCEMENT V-Y FLAP FOR VULVAR RECONSTRUCTION AFTER SURGERY FOR VULVAR MALIGNANCIES. 70
OP29.03: Identification of parametria by 2D-3D ultrasound in patients with cervical cancer: new perspectives and future applications 70
BRCA mutational status, initial disease presentation, and clinical outcome in high-grade serous advanced ovarian cancer: a multicenter study 70
Limits of ¹⁸F-fluorodeoxyglucose positron emission tomography in recurrence diagnosis of borderline ovarian tumor. 70
The effect of surgery for endometrioma on ovarian reserve evaluated by antral follicle count: a systematic review and meta-analysis. 70
null 69
Imaging strategy in recurrent ovarian cancer: a practical review 69
Olaparib, PARP1 inhibitor in ovarian cancer 69
Late aortic lymphocele and residual ovary syndrome after gynecological surgery. 66
null 65
Complete remission after neoadjuvant chemotherapy of an advanced vulvar cancer patient: A case report 65
Outcome of patients with advanced ovarian cancer who do not undergo debulking surgery: a single institution retrospective review 65
Isolated contralateral groin relapse in vulvar cancer. 65
Use of adjuvant therapy in patients with FIGO stage III endometrial carcinoma: a multicenter retrospective study. 64
Ovarian cancer long term survivors and their genetic predisposition: a case report 64
Thinking twice before abandoning first-line chemotherapy in ovarian cancer: report of two cases and literature review. Passing from tri-weekly to weekly regimens 64
Late breast cancer recurrence to the uterine cervix with a review of the literature 64
Immune check-point in endometrial cancer 64
Immunotherapy of ovarian cancer: the role of checkpoint inhibitors 63
Targeted drug delivery via folate receptors in recurrent ovarian cancer: a review. 63
Epistaxis in Weekly Paclitaxel Regimen: Is it Really Related to Schedule? 62
Risk-reducing surgery in BRCA 1/2 mutation carries: a point of view 62
Bmi is a key prognostic factor in stage iiic-iv ovarian cancer diagnosed prior 65 years old: a 10-year survival analysis 62
Hemoglobin variation and blood transfusion rates in patients affected by locally advanced cervical cancer undergoing neo-adjuvant chemotherapy followed by radical surgery: the role of erythropoietic growth factors 62
Erythropoiesis-stimulating agents in gynecological malignancies: a study-level meta-analysis 61
Modified gluteal fold advancement V-Y flap for vulvar reconstruction after surgery for vulvar malignancies 61
Inguinofemoral Lymphadenectomy: Randomized Trial Comparing Inguinal Skin Access Above or Below the Inguinal Ligament 61
PI3K/AKT/mTOR pathway in ovarian cancer treatment: are we on the right track? 60
Predictors of postoperative morbidity after cytoreduction for advanced ovarian cancer. Analysis and management of complications in upper abdominal surgery 60
Minimally Invasive Surgical Approach for Treatment of Isolated Endometrial Cancer Recurrence in an Ultra-Morbidly Obese Patient 58
null 57
Hormone therapy in oophorectomized BRCA1/2 mutation carriers 56
Simple extrafascial trachelectomy and pelvic bilateral lymphadenectomy in early stage cervical cancer 56
null 56
Secondary analyses from a randomized clinical trial: age as the key prognostic factor in endometrial carcinoma 56
Olfactomedin-4 regulation by estrogen in the human endometrium requires epidermal growth factor signaling 55
Intraperitoneal chemotherapy by ultrasound-guided direct puncture in recurrent ovarian cancer: feasibility, compliance, and complications. 55
First-line treatment of advanced ovarian cancer: current research and perspectives. 54
From the tailoring of adjuvant treatment to the tailoring of pelvic and aortic lymphadenectomy in stage i endometrial cancer 53
Diet and chemotherapy: the effects of fasting and ketogenic diet on cancer treatment 53
null 53
Hearing loss after cisplatin-based chemoradiotherapy for locally advanced head and neck cancer: a prospective single-institution study 52
Totale 7.809
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.927
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.927
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020685 0 0 0 0 0 0 0 0 264 241 114 66
2020/2021663 67 103 27 42 16 65 11 47 80 91 67 47
2021/20221.346 6 74 142 34 185 55 23 165 95 101 169 297
2022/20231.441 306 299 61 184 135 134 38 66 140 11 50 17
2023/2024731 47 99 19 76 82 85 27 96 4 69 64 63
2024/20251.315 39 164 96 48 180 126 117 83 462 0 0 0
Totale 10.000